1-2 of 2
Nicolai Haertel, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Imatinib Treatment Induces Growth and Survival Promoting MAPK1/2 in Hematopoietic Cell Lines Expressing BCR-ABL T315I .

Nicolai Haertel, MD, Thomas Klag, Benjamin Hanfstein, MD, Martin C. Mueller, MD, Ruediger Hehlmann, MD, Andreas Hochhaus, MD, Paul La Rosee, MD
Journal: Blood
Blood (2007) 110 (11): 3460.
https://doi.org/10.1182/blood.V110.11.3460.3460
Published: 2007
Journal Articles

MAPK-Activation in CD34+ CML Stem Cells Induced by Selective Abl-Inhibitors Is Not Observed Using the Combined Src/Abl-Inhibitor Dasatinib.

Paul La Rosee, MD, Nicolai Haertel, MD, Thomas Klag, Heiko Konig, MD, Ruediger Hehlmann, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2007) 110 (11): 652.
https://doi.org/10.1182/blood.V110.11.652.652
Published: 2007